2739 results about "Aqueous solubility" patented technology

An acid fracturing method is provided in which the acid is generated in the fracture by hydrolysis of a solid acid-precursor selected from one or more than one of lactide, glycolide, polylactic acid, polyglycolic acid, a copolymer of polylactic acid and polyglycolic acid, a copolymer of glycolic acid with other hydroxy-, carboxylic acid-, or hydroxycarboxylic acid-containing moieties, and a copolymer of lactic acid with other hydroxy-, carboxylic acid or hydroxycarboxylic acid-containing moieties. The solid acid-precursor may be mixed with a solid acid-reactive material to accelerate the hydrolysis and/or coated to slow the hydrolysis. Water-soluble liquid compounds are also given that accelerate the hydrolysis. The method ensures that the acid contacts fracture faces far from the wellbore.

An aqueous binder composition containing a water-soluble and substantially infinitely water-dilutable free radical polymerized adduct of a monomeric carboxylic acid component and a monomeric hydroxyl component, polymerized in the presence of a chain transfer agent, and the related method of its use for making glass fiber products, especially fiberglass insulation.

A molded component or article for biomedical use is prepared from a crosslinkable non-water-soluble polymer which when crosslinked and saturated with water forms a hydrogel. The polymer is formulated as a composition containing a non-aqueous diluent in addition to the polymer, the diluent being present in a volumetric proportion that is substantially equal to the volumetric proportion of water in the hydrogel that would be formed when the polymer is crosslinked and saturated with water. The composition is cast in a mold where the composition is exposed to conditions that cause crosslinking to occur by a reaction to which the non-aqueous diluent is inert. The crosslinking reaction produces a molded non-aqueous gel which is then converted to a hydrogel by substituting an aqueous liquid such as water or physiological saline for the non-aqueous diluent. The use of a molding composition whose curing consists essentially entirely of crosslinking results in a molding process that entails little or no shrinkage, and dimensional integrity is maintained up through the formation of the hydrogel by using the non-aqueous diluent in essentially the same volumetric proportion as water in the hydrogel.

A method of treating a treatment zone in a well to reduce the permeability of the treatment zone including the steps of: introducing into the treatment zone a water-based treatment fluid comprising: an aqueous silica sol; and a water-soluble chemical activator for gelling the silica sol, wherein the chemical activator is selected from the group consisting of: phytic acid, methylglycinediacetic acid, a water-soluble polyepoxysuccinic acid, salicylic acid, ascorbic acid, tannic acid, and an alkali metal salt or ammonium salt of any of the foregoing; and shutting in treatment zone for at least a sufficient time to allow the treatment fluid to in-situ form a solid gel at a design temperature for the method. Alternatively, a first treatment fluid including the aqueous silica sol and a second treatment fluid including the chemical activator can be introduced into the treatment zone separately, in any order.

The present invention is directed to the oral osmotic delivery of therapeutic compounds that have limited solubility in an aqueous environment due to inherent hydrophobicity or to saturation limitations in the core of the osmotic system. The present invention is suitable for the osmotic delivery of glipizide and other hydrophobic drugs, but runs the spectrum to other therapeutic agents with higher aqueous solubilities, yet having a solubility limitation in an osmotic dosage unit due to high drug load.

An article comprising: a functionalized substrate comprising: a composition susceptible to aqueous attack, comprising a water-soluble material, a partially water soluble material, a water-dispersible materials, a water-disintegrating materials, and mixtures thereof; a plurality of microcapsules encapsulating a perfume, wherein said plurality of microcapsules is incorporated with said functionalized substrate; and a total perfume loading level of from about 1% to about 95% by weight of said functionalized substrate.

A method for producing biofuels is provided. A method of making biofuels includes dewatering substantially intact algal cells to make an algal biomass, extracting neutral lipids from the algal biomass, and esterifying the neutral lipids with a catalyst in the presence of an alcohol. The method also includes separating a water soluble fraction comprising glycerin from a water insoluble fraction comprising fuel esters and distilling the fuel esters under vacuum to obtain a C16 or shorter fuel esters fraction, a C16 or longer fuel ester fraction, and a residue comprising carotenoids and omega-3 fatty acids. The method further includes hydrogenating and deoxygenating at least one of (i) the C16 or shorter fuel esters to obtain a jet fuel blend stock and (ii) the C16 or longer fuel esters to obtain a diesel blend stock.

The invention described herein relates to methods for reducing and/or stopping bleeding or fluid loss from open wound, denuded tissue, or burned skin, comprising the step of applying to the open wound, denuded tissue or burned skin a gel-forming composition comprising at least one of the following compositions: a polyacrylic acid having the structural formula [CH₂═CHCO₂H]_n, where n is between 10,000 and 70,000; a polyacrylic acid and a desiccated water soluble organic or inorganic base; polyacrylic acid and a desiccated poorly soluble basic salt, and a polyvinyl alcohol having the structural formula of [CH₂═CHOH]_n, where n is between 15,000 and 150,000. When the gel-forming composition is applied to the open wound, denuded tissue, or burned skin, its ions react therein in the presence of water from blood or body fluid therein to form an aqueous gel or mucilage having sufficient viscosity and adhesiveness to cover and adhere to the open wound, denuded tissue, or burned skin so that bleeding or fluid loss is thereby reduced and/or stopped.

A method for preparing carbon nitride quantum dots comprises the following steps of (1) material preparation, (2) drying and tabletting, (3) heating, (4) separation and (5) drying. Sodium chloride crystals are used as a template, the preparing process is simple and low in cost, and the sodium chloride crystals can be easily removed through water dissolution; melamine is used as the raw material, and annular carbon nitride basic structural units exist in melamine molecules, so that the yield of preparing the quantum dots is high, and product size uniformity is good; the prepared quantum dots are high in specific area, good in water solubility and good in dispersity, have strong fluorescent radiation visible under naked eyes, and have wide application prospects in the fields of fluorescence detection, light emitting devices, biomarker and the like.

An aqueous ink composition comprised of (1) a quaternary compound selected from the group consisting of (a) imidazolinium quaternary salts, (b) phosphonium quaternary salts, and (c) an ammonium quaternary salt; (2) a liquid ink vehicle; (3) a paper-curl reducing compound; (4) a lightfastness component; (5) a lightfastness antioxidant; (6) a substantially water soluble organic salt or a substantially water soluble inorganic salt; (7) a biocide; and (8) a colorant.

The present invention relates to a nanoparticle composition comprising a camptothecin derivative, solid polyethyleneglycol and an anti-associative agent, and the process for preparing the same. Specifically, the present invention provides a composition comprising a nanoparticle of the camptothecin derivative, which is prepared by solid-dispersing the poorly water soluble camptothecin derivative in polyethyleneglycol and dissolving the solid dispersions in an aqueous solution containing an anti-associative agent. The composition of the present invention stabilizes the camptothecin derivative lactone form in body fluid for effective anticancer activity.

The invention provides water-solubility silver nanowire writing ink and a using method of the water-solubility silver nanowire writing ink for preparing a transparent conductive thin film. The water-solubility silver nanowire writing ink is characterized in that the silver nanowire writing ink containing a water-solubility polymer is prepared, and then the writing ink forms the conductive thin film on a transparent substrate by a one-step method. The water-solubility polymer can realize the firm adhesive bonding between the silver nanomwire and the substrate and solves the difficult problem of poor adhesive bonding performance between the silver nanowire and the substrate; the one-step method greatly simplifies the productive technology of the silver nanowire transparent conductive thin film; an organic solvent is not used in the whole production process; and therefore, the water-solubility silver nanowire writing ink is environment-friendly and pollution-free and has very good practical application value.

A chemical mechanical polishing aqueous dispersion includes (A) a sulfonic acid group-containing water-soluble polymer, (B) an amino acid, (C) abrasive grains, and (D) an oxidizing agent.

Particles, compositions, and methods that aid particle transport in mucus are provided. The particles, compositions, and methods may be used, in some instances, for ophthalmic and/or other applications. In some embodiments, the compositions and methods may involve modifying the surface coatings of particles, such as particles of pharmaceutical agents that have a low aqueous solubility. Such compositions and methods can be used to achieve efficient transport of particles of pharmaceutical agents though mucus barriers in the body for a wide spectrum of applications, including drug delivery, imaging, and diagnostic applications. In certain embodiments, a pharmaceutical composition including such particles is well-suited for ophthalmic applications, and may be used for delivering pharmaceutical agents to the front of the eye and/or the back of the eye.

The compositions disclosed herein are for use as controlled release therapeutics for the treatment of a wide variety of diseases. In particular, the compositions provide water soluble bioactive agents, organic ions and polymers where the bioactive agent is efficiently released over time with minimal degradation products. The resulting controlled release composition is capable of administration in a decreased dose volume due to the high drug content and predominance of non-degraded bioactive agent after release. Additionally, the compositions, of the present invention are capable of long term, sustained releases.

Aqueous dilutions of acidic ternary compositions having unusually synergistic antimicrobial activity against Staphylococcus aureus and Salmonella choleraesuis microorganisms are disclosed. The compositions encompass ternary component mixtures of an alpha-hydroxycarboxylic acid, a monohydric water soluble alkanol and an anionic tenside having a Ternary Ratio residing within a defined phase region wherein synergistic antimicrobial activity is observed; whereas mixtures outside of the defined phase region and those lacking any one of the components do not exhibit synergistic activity. Compositions, methods and articles employing the inventive ternary synergistic compositions, and their utility in sanitizing and disinfecting hard surfaces are described.

A process for the preparation of a particulate material by a controlled agglomeration method, i.e. a method that enables a controlled growth in particle size. The method is especially suitable for use in the preparation of pharmaceutical compositions containing a therapeutically and/or prophylactically active substance which has a relatively low aqueous solubility and/or which is subject to chemical decomposition. The process comprising i) spraying a first composition comprising a carrier, which has a melting point of about 5° C. or more which is present in the first composition in liquid form, on a second composition comprising a material in solid form, the second composition having a temperature of at the most a temperature corresponding to the melting point of the carrier and/or the carrier composition and ii) mixing or others means of mechanical working the second composition onto which the first composition is sprayed to obtain the particulate material.

The invention discloses modified graphene and a preparation method thereof. The method comprises the following steps: performing oxidation treatment on natural flake graphite to obtain graphene oxide, and enabling graphene oxide to react with sulfoxide chloride to obtain graphene containing acyl chloride groups on the surface; then performing nucleophilic substitution reaction with 1,3-propane diamine, cyanuric chloride and a dihydric alcohol compound in sequence to obtain water-soluble graphene with hydroxyl groups on the surface, wherein the hydroxyl group content is 0.005-0.02%. Obtained modified graphene has relatively good water solubility, and is beneficial to stable dispersion of graphene; by adopting the characteristics of modified graphene, modified graphene can be mixed and uniformly dispersed with other concrete preparation materials very conveniently to prepare a reinforcing and toughening concrete product. In addition, operating conditions for preparing modified graphene can be easily met; moreover, modified graphene disclosed by the invention is easily-available in raw material, can be used for effectively reducing the cost and improving the economic benefits, and has relatively good application prospects.

Disclosed and claimed is a microemulsion-based demulsifier composition and a method of demulsifying an emulsion comprising hydrocarbon and water. The demulsifier composition includes (i) an oil-like phase comprising at least one nonionic surfactant having a hydrophilic-lipophilic balance (HLB) of less than about 9; (ii) a coupling agent capable of stabilizing the demulsifier composition; (iii) at least one water-soluble or dispersible nonionic surfactant that is different from the at least one nonionic surfactant in the oil-like phase; (iv) at least one additional surfactant selected from anionic, cationic, amphoteric, and combinations thereof; (v) at least one nonionic demulsifier; and (vi) water.

The invention discloses a nano-silver antibacterial composite modified by modified chitosan and a preparing method of the nano-silver antibacterial composite. According to the nano-silver antibacterial composite and the preparing method of the nano-silver antibacterial composite, the chitosan with the small molecule quantiy and good water solubility is selected and used as a raw material, chemical modification is conducted on the chitosan by using small molecules which are capable of having chelation with nano-silver particles, the modified chitosan is arranged on the surfaces of the nano-silver particles in a covalent modification mode, and the novel nano-silver antibacterial composite is prepared. The prepared nano-silver antibacterial composite modified by the modified chitosan has good water solubility and dispersibility and can be stably dispersed in a water solution in a long term without aggregation under the conditions of high salinity and wide pH. The prepared nano-silver antibacterial composite modified by the modified chitosan enables the antibacterial property of the chitosan and the antibacterial property of nano-silver to be in effective synergy, the antibacterial performance is good, and the nano-silver antibacterial composite can serve as a water coating agent to perform the surface antibacterial function on the surfaces of materials and can also permeate into fiber type materials to perform the deep internal antibacterial function.

An artificial plasma-like substance having at least one water soluble polysaccharide oncotic agent selected from the group consisting of high molecular weight hydroxyethyl starch, low molecular weight hydroxyethyl starch, dextran 40 and dextran 70, which is buffered by lactate and has a pre-administration pH of between 4 and 6.5 is disclosed. In one embodiment, the artificial plasma-like solution may have at least two water soluble polysaccharide oncotic agents one of which is eliminated from the circulation slowly and the other of which is eliminated from the circulation quickly. Supplementation of the plasma-like solution with certain ions is described. A system for administration of the plasma-like solution to a subject wherein the system comprises a first and second solution each having particular buffers is described. Methods for the administration of the plasma-like solution are also disclosed.

The present invention provides (i) a water absorbing agent which is excellent in a water absorbing physical properties, in particular water absorbing speed and has a great bulk specific gravity and (ii) a method for producing the water absorbing agent. The method for producing the water absorbing agent includes a surfactant adding step of adding a surfactant whose HLB is 10 or less. The surfactant adding step is the step of adding a dispersion liquid, which contains the surfactant equivalent to 30 parts by weight to 150 parts by weight, relative to 1000000 parts by weight of a water absorbent resin solid content, and the surfactant adding step is carried out after a drying step. Further, in a case where a water-soluble polyvalent metal salt adding step is carried out after the drying step, the surfactant adding step is carried out after the water-soluble polyvalent metal salt adding step.

The present invention provides a process for preparing cross-linked sodium hyaluronate microspheres capable of being adopted as an emboliaztion agent by adopting sodium hyaluronate as a raw material. The process comprises the following steps: preparing a sodium hyaluronate alkaline solution gel with a concentration of 10-30% g/ml; adding the sodium hyaluronate alkaline solution gel to an emulsifier-containing oil phase, and carrying out high speed emulsification through a shearing machine, wherein an emulsification speed is 500-2000 rpm, and a time is 10-20 min; adding a certain amount of a cross-linking agent, stirring for 4-6 h at a room temperature, carrying out a cross-linking reaction, and standing overnight after completing the reaction, wherein a mass percentage of the cross-linking agent in the oil phase is 0.2-2%; and adopting a water-soluble organic solvent to wash to remove the oil phase remained on the surface of the microspheres, and finally drying to obtain the cross-linked sodium hyaluronate microspheres. According to the present invention, the preparation process is simple; and the size of the obtained microspheres is suitable for routine blood vessel emboliaztion, and the obtained microspheres have characteristics of controllable particle size, good microsphere shape, easy screening, elasticity, expandibility, no toxic-side effect on human body, good biocompatibility, good biodegradability, and ensured clinical safety.

The invention discloses a carboxylic acid compound as well as a preparation method and application thereof. When the carboxylic acid compound is applied to extraction separation of metal ions, the separation coefficient is high, the reverse extraction acidity is low, the load rate is high, and the reverse extraction rate is high. The carboxylic acid compound serving as an extraction agent is highin stability and low in water solubility, so that the extraction process is stable, the environmental pollution can be reduced, and the cost is reduced. The carboxylic acid compound disclosed by the invention is low in cost, has a great application prospect and can be used for various systems such as ternary battery recovery and battery-grade nickel sulfate preparation.

The invention designs and synthesizes a cationic water-soluble column [5] aromatic hydrocarbon compound. The structure of the compound has a column frame containing five benzene rings, and five trimethylamine groups are respectively connected to upper and lower edges of the column frame. The compound is column aromatic hydrocarbon containing multiple recognition sites, has good solubility in water, and can be complexed with silver ions by cationic trimethylamine groups in a pure water phase to form a stable complex. Experiments indicate that in the water solution of the cationic water-soluble column aromatic hydrocarbon, only addition of Ag<+> is capable of remarkably reinforcing the ultraviolet absorption peak of the cationic water-soluble column aromatic hydrocarbon at 293nm, and addition of other cationic ions cannot change ultraviolet absorption of the cationic water-soluble column aromatic hydrocarbon at 293nm in the water solution. Therefore, the column aromatic hydrocarbon has a good selective ultraviolet recognition capability for Ag<+>, can be used as an Ag<+> acceptor molecule to detect silver ions in a pure water phase. Titration experiments indicate that the lowest detection limit of column aromatic hydrocarbon for Ag<+> is 1.25*10<-5>M.

The invention belongs to the technical field of materials, and specifically relates to a preparation method of melamine/formaldehyde resin cladded melamine phosphatic microcapsules for a fire retardant. The preparation method comprises the following concrete steps of: firstly adding 100g of MP and 0.1-3g of a dispersant into a solvent of 200-500ml, dispersing by stirring for 0.4-0.6 hours, adding a melamine/formaldehyde resin prepolymer into the system, dispersing by incessant stirring for 0.4-0.6 hours, heating up to 60-120 DEG C, reacting for 1-5 hours, filtering and drying to obtain a melamine/formaldehyde resin cladded MP microcapsule powder. The microcapsule coating is compact and uniform with good fluidity and greatly reduced water-solubility, can be used as a fire retardant for high-molecular materials such as polyolefin and nylon, and can be used in the flame retardation for materials such as timber, fabric, paintings and the like.

The invention discloses a mutant human plasminogen kringle5 gene mK5 and an amplification primer of the mK5 gene, the mutant human plasminogen kringle5 gene modified by adding glutathione-S-transferase before the gene mK5, and a method for preparing protein mK5 recombinant protein of two gene codes, glutathioneS transferase (GST)-mK5 fusion protein and two proteins, wherein the mK5 gene and the GST-mK 5 gene can be applied to preparing medicaments for treating angiogenesis diseases. By the invention, the number of exogenous amino acid in the recombinant K5 protein molecules obtained by a gene engineering method is remarkably reduced, the K5 bioactivity of the obtained mK5 is improved, while the mK5 activity of the GST-mK5 fusion protein is maintained, the stability and water solubility of the protein are improved, the purification steps of an expressed product are simplified, and the purity of the product is improved.

The invention relates to a polyacrylate/nanometer ZnO composite finishing agent suitable for the base coating of clothing leathers, instep leathers and corrected leathers and a preparation method of the polyacrylate/nanometer ZnO composite finishing agent. The polyacrylate/nanometer ZnO composite finishing agent comprises the following raw materials by weight: 22wt%-28wt% of acrylic ester monomer, 2wt%-5wt% of emulsifying agent, 0.4 wt%-0.8 wt% of initiating agent, 0.2wt%-1.5 wt% of nanometer ZnO, 0.6 wt%- 5wt% of water-solubility high polymer materials, and the rest of deionized water. The preparation method comprises the following steps of: firstly, carrying out surface modification on the nanometer ZnO by adopting a water-solubility high molecular polymer, enabling the nanometer ZnO tobe uniformly dispersed in a water solution, then triggering the acrylic ester monomer to polymerize in site, and preparing the polyacrylate/nanometer ZnO composite finishing agent. Compared with the pure polyacrylate emulsion, the polyacrylate/nanometer ZnO composite finishing agent has the advantages that the water tolerance, the elongation at break, the air permeability and the water vapor permeability of a finished leather sample are all substantially increased.

The invention relates to a preparation and an application of an indicator fixation test paper for the heavy metal ion detection. The preparation comprises three steps of silica sol gel synthesis, indicator fixation and color comparison. Tetraethoxysilane and siloxane containing hydrophobic function groups, which are adopted as a mixed silicon source, are hydrolyzed under acidic conditions to synthesize the silica sol gel. The gel is mixed with a specific hydrophobic or water-soluble metal ion indicator, is uniformly coated on a nitric acid-acetic acid mixed cellulose film and is dried under the protection of nitrogen. The test paper of the invention can be used for determining trace heavy metal ions in water and can respectively, rapidly and semi-quantitatively determine various trace heavy metal ions in water within 10min.

The invention discloses a preparation method of a nano-structure WC-Co composite powder, and belongs to the field of an alloy preparation method. The method comprises the following steps in sequence: adding a carbonic powder material which is excessive to tungsten, vanadium and chromium carbides into water-soluble saturated mixed aqueous solution of tungsten-containing compound, cobalt-containing compound, chromium-containing compound and vanadium-containing compound to adsorb the saturated composite salt solution; dehydrating and drying to form a nano-scale composite salt thin layer on the surface of the carbonic powder material; removing crystal water out of the composite salt at the temperature below 500 DEG C under a condition of isolating air, and decomposing the composite salt into composite oxide of tungsten oxide, chromium hemitrioxide, vanadium oxide and cobalt oxide, further heating, and reducing and carbonizing the composite oxide on the surface of the carbonic powder material to generate the WC-Co nano-structure composite powder at the temperature below 850 DEG C. The preparation is a simpler and more reliable novel preparation method of the nano WC-Co composite powder by a direct carbonization method.